Phenotypic Screening Using Patient-Derived Induced Pluripotent Stem Cells Identified Pyr3 as a Candidate Compound for the Treatment of Infantile Hypertrophic Cardiomyopathy
Released on J-STAGE: September 26, 2018 |
Volume 59
Issue 5
Pages 1096-1105
Taku Sakai, Atsuhiko T. Naito, Yuki Kuramoto, Masamichi Ito, Katsuki Okada, Tomoaki Higo, Akito Nakagawa, Masato Shibamoto, Toshihiro Yamaguchi, Tomokazu Sumida, Seitaro Nomura, Akihiro Umezawa, Shigeru Miyagawa, Yoshiki Sawa, Hiroyuki Morita, Jong-Kook Lee, Ichiro Shiojima, Yasushi Sakata, Issei Komuro